YERXA BENJAMIN R has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 400000 shares of Opus Genetics, Inc. ($IRD) on January 22, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Opus Genetics, Inc. | $IRD | YERXA BENJAMIN R | President | A | Common Stock | 400000 | $0.00 | 719,005.0000 | 70,636,887 | 125.39% | 0.57% |
| Oct. 22, 2025 | Opus Genetics, Inc. | $IRD | YERXA BENJAMIN R | President | F | Common Stock | 23795 | $1.95 | 319,005.0000 | 70,636,887 | 6.94% | 0.03% |
| Nov. 21, 2024 | Opus Genetics, Inc. | $IRD | YERXA BENJAMIN R | President | P | Common Stock | 10000 | $0.98 | 342,800.0000 | 26,145,080 | 3.00% | 0.04% |
| Nov. 7, 2024 | Opus Genetics, Inc. | $IRD | YERXA BENJAMIN R | President | A | Common Stock | 332800 | $0.00 | 332,800.0000 | 26,145,080 | 9999.99% | 1.27% |
| June 20, 2024 | Clearside Biomedical, Inc. | $CLSDQ | YERXA BENJAMIN R | Not found | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Clearside Biomedical, Inc. | $CLSDQ | YERXA BENJAMIN R | Not found | P | Common Stock | 7813 | $1.31 | 17,957.0000 | 0 | 77.02% | 0.00% |
| June 22, 2023 | Clearside Biomedical, Inc. | $CLSDQ | YERXA BENJAMIN R | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |